pharmaceutical-technology.com
53%
220
Gilead sets Covid-19 drug candidate remdesivir price at $390 per vial
Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.Gilead Sciences has set the price of its investigational Covid-19 drug remdesivir at $390 per vial for the US and governments of other developed countries. Current treatment patterns reveal that most patients may require a five-day treatment course, which involves six vials of remdesivir, pricing the course at $2,340 per patient.